Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, Yi-Min Zheng, Claire Carlin, Mirela Anghelina, Patrick Stevens, Soledad Fernández, Daniel M. Jones, Gerard Lozanski, Ashish R. Panchal, Linda J. Saif, Eugene M. Oltz, Kai Xu, Richard J. Gumina, Shan‐Lu Liu
Topics & Concepts
NeutralizationInfectivityVirologyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MutationCoronavirus disease 2019 (COVID-19)TiterImmune escape2019-20 coronavirus outbreakMolecular biologyImmune systemVirusGeneImmunologyGeneticsMedicineInfectious disease (medical specialty)DiseaseInternal medicineOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesBacillus and Francisella bacterial research